Kura Oncology is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. Their novel therapies are designed to selectively target cancer cells, advancing a pipeline for solid tumors and blood cancers.
- Category
- Precision Oncology
- Stage
- Public
- Employees
- 118
- HQ
- San Diego, United States
- Founded
- 2014
- Funding
- $63M